Raymond James & Associates Vertex Pharmaceuticals Inc Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Raymond James & Associates holds 325,391 shares of VRTX stock, worth $133 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
325,391
Previous 310,646 4.75%
Holding current value
$133 Million
Previous $146 Million 3.93%
% of portfolio
0.09%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$460.0 - $505.78 $6.78 Million - $7.46 Million
14,745 Added 4.75%
325,391 $151 Million
Q2 2024

Jul 19, 2024
SELL
$392.81 - $485.53 $3.19 Million - $3.94 Million
-8,111 Reduced 2.54%
310,646 $146 Million
Q1 2024

Apr 22, 2024
SELL
$407.69 - $446.08 $9.65 Million - $10.6 Million
-23,660 Reduced 6.91%
318,757 $133 Million
Q4 2023

Jan 16, 2024
BUY
$343.0 - $410.68 $15,092 - $18,069
44 Added 0.01%
342,417 $139 Million
Q3 2023

Oct 24, 2023
BUY
$338.18 - $362.46 $3.62 Million - $3.88 Million
10,703 Added 3.23%
342,373 $119 Million
Q2 2023

Jul 25, 2023
SELL
$314.42 - $351.91 $4.94 Million - $5.52 Million
-15,698 Reduced 4.52%
331,670 $117 Million
Q1 2023

Apr 14, 2023
SELL
$283.23 - $323.1 $7.07 Million - $8.06 Million
-24,958 Reduced 6.7%
347,368 $109 Million
Q4 2022

Feb 08, 2023
BUY
$285.76 - $321.48 $2.46 Million - $2.76 Million
8,596 Added 2.36%
372,326 $108 Million
Q3 2022

Oct 25, 2022
BUY
$273.83 - $305.53 $852,432 - $951,114
3,113 Added 0.86%
363,730 $105 Million
Q2 2022

Aug 12, 2022
SELL
$234.96 - $292.55 $13.3 Million - $16.6 Million
-56,784 Reduced 13.6%
360,617 $102 Million
Q1 2022

May 11, 2022
SELL
$221.42 - $260.97 $8.79 Million - $10.4 Million
-39,682 Reduced 8.68%
417,401 $109 Million
Q4 2021

Feb 08, 2022
BUY
$177.01 - $223.45 $3.12 Million - $3.93 Million
17,602 Added 4.01%
457,083 $100 Million
Q3 2021

Nov 02, 2021
BUY
$181.39 - $202.99 $23.9 Million - $26.7 Million
131,559 Added 42.72%
439,481 $79.7 Million
Q2 2021

Aug 11, 2021
SELL
$187.49 - $221.1 $542,596 - $639,863
-2,894 Reduced 0.93%
307,922 $62.1 Million
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $5.49 Million - $6.4 Million
26,510 Added 9.32%
310,816 $66.8 Million
Q4 2020

Feb 12, 2021
BUY
$207.01 - $276.09 $1.79 Million - $2.39 Million
8,641 Added 3.13%
284,306 $67.2 Million
Q3 2020

Nov 04, 2020
SELL
$255.65 - $303.1 $259,484 - $307,646
-1,015 Reduced 0.37%
275,665 $75 Million
Q2 2020

Jul 28, 2020
BUY
$225.48 - $295.8 $7.44 Million - $9.76 Million
32,988 Added 13.54%
276,680 $80.3 Million
Q1 2020

Apr 21, 2020
SELL
$199.77 - $247.81 $21 Million - $26.1 Million
-105,333 Reduced 30.18%
243,692 $58 Million
Q4 2019

Feb 12, 2020
SELL
$166.71 - $223.91 $2.64 Million - $3.54 Million
-15,819 Reduced 4.34%
349,025 $76.4 Million
Q3 2019

Nov 07, 2019
SELL
$166.23 - $187.09 $2.69 Million - $3.03 Million
-16,191 Reduced 4.25%
364,844 $61.8 Million
Q2 2019

Aug 06, 2019
SELL
$164.61 - $190.37 $2.53 Million - $2.93 Million
-15,397 Reduced 3.88%
381,035 $69.9 Million
Q1 2019

May 06, 2019
SELL
$163.73 - $194.7 $864,166 - $1.03 Million
-5,278 Reduced 1.31%
396,432 $72.9 Million
Q4 2018

Feb 11, 2019
SELL
$151.91 - $192.21 $3.49 Million - $4.42 Million
-22,974 Reduced 5.41%
401,710 $66.6 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $2.11 Million - $2.43 Million
12,582 Added 3.05%
424,684 $81.9 Million
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $2.36 Million - $2.75 Million
-16,209 Reduced 3.78%
412,102 $70 Million
Q1 2018

May 14, 2018
BUY
$151.6 - $177.13 $3.14 Million - $3.66 Million
20,682 Added 5.07%
428,311 $69.8 Million
Q4 2017

Feb 14, 2018
BUY
$137.28 - $155.55 $285,679 - $323,699
2,081 Added 0.51%
407,629 $61.1 Million
Q3 2017

Nov 13, 2017
BUY
$148.13 - $162.24 $5.98 Million - $6.55 Million
40,394 Added 11.06%
405,548 $61.7 Million
Q2 2017

Aug 14, 2017
BUY
N/A
365,154
365,154 $47.1 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email